A detailed history of Forsta Ap Fonden transactions in Johnson & Johnson stock. As of the latest transaction made, Forsta Ap Fonden holds 637,738 shares of JNJ stock, worth $97.2 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
637,738
Previous 584,738 9.06%
Holding current value
$97.2 Million
Previous $85.5 Million 20.93%
% of portfolio
0.81%
Previous 0.77%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$145.48 - $167.38 $7.71 Million - $8.87 Million
53,000 Added 9.06%
637,738 $103 Million
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $7.1 Million - $7.76 Million
-49,200 Reduced 7.76%
584,738 $85.5 Million
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $11 Million - $11.6 Million
71,000 Added 12.61%
633,938 $100 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $2.77 Million - $3.02 Million
-19,000 Reduced 3.26%
562,938 $88.2 Million
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $5.71 Million - $6.4 Million
-36,662 Reduced 5.93%
581,938 $90.6 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $4.65 Million - $5 Million
-30,100 Reduced 4.64%
618,600 $102 Million
Q1 2023

Apr 21, 2023

SELL
$151.05 - $180.26 $16 Million - $19.1 Million
-105,900 Reduced 14.03%
648,700 $101 Million
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $22 Million - $24.6 Million
137,100 Added 22.2%
754,600 $133 Million
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $5.65 Million - $6.28 Million
35,000 Added 6.01%
617,500 $101 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $1.72 Million - $1.9 Million
10,200 Added 1.78%
582,500 $103 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $5.47 Million - $6.21 Million
-34,600 Reduced 5.7%
572,300 $101 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $717,278 - $795,846
-4,600 Reduced 0.75%
606,900 $104 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $4.94 Million - $5.49 Million
30,600 Added 5.27%
611,500 $98.8 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $10.3 Million - $11.1 Million
64,700 Added 12.53%
580,900 $95.7 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $1.99 Million - $2.22 Million
13,000 Added 2.58%
516,200 $84.8 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $8.27 Million - $9.49 Million
60,300 Added 13.61%
503,200 $79.2 Million
Q3 2020

Feb 19, 2021

BUY
$140.38 - $153.83 $62.2 Million - $68.1 Million
442,900 New
442,900 $65.9 Million
Q3 2020

Oct 22, 2020

SELL
$140.38 - $153.83 $53.5 Million - $58.7 Million
-381,408 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $7.07 Million - $8.54 Million
54,900 Added 16.81%
381,408 $53.6 Million
Q1 2020

May 04, 2020

BUY
$111.14 - $153.99 $32.5 Million - $45.1 Million
292,700 Added 865.77%
326,508 $42.8 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $127,500 - $146,440
1,000 Added 3.05%
33,808 $4.93 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $11.3 Million - $12.7 Million
-89,100 Reduced 73.09%
32,808 $4.25 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $12.8 Million - $14 Million
-97,221 Reduced 44.37%
121,908 $17 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $7.3 Million - $8.12 Million
-58,100 Reduced 20.96%
219,129 $30.6 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $902,505 - $1.09 Million
7,347 Added 2.72%
277,229 $35.8 Million
Q3 2018

Nov 07, 2018

SELL
$121.58 - $142.88 $3.36 Million - $3.94 Million
-27,600 Reduced 9.28%
269,882 $37.3 Million
Q2 2018

Aug 15, 2018

SELL
$119.4 - $131.76 $2.83 Million - $3.12 Million
-23,700 Reduced 7.38%
297,482 $36.1 Million
Q1 2018

May 09, 2018

BUY
$125.1 - $148.14 $1.48 Million - $1.75 Million
11,800 Added 3.81%
321,182 $41.2 Million
Q4 2017

Feb 08, 2018

SELL
$131.22 - $143.62 $1.67 Million - $1.82 Million
-12,700 Reduced 3.94%
309,382 $43.2 Million
Q3 2017

Oct 31, 2017

BUY
$129.47 - $135.38 $41.7 Million - $43.6 Million
322,082
322,082 $41.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $398B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.